Comparing two surgical approaches for esophageal cancer
Part of Cancer clinical trials.
This study compares two ways to perform surgery for esophageal cancer. The goal is to see if doing the surgery with minimally invasive techniques (using small incisions and cameras) is as safe and effective as a hybrid method that uses both small and larger incisions. Your participation may help doctors improve surgical options for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old. If you are between 70 and 80, you need a health score (G8) of at least 14 or approval from a geriatric specialist.
- You have been diagnosed with squamous cell carcinoma or adenocarcinoma of the esophagus or the area where the esophagus meets the stomach (esophagogastric junction).
- Your cancer is at a stage where it can potentially be completely removed with surgery. This includes certain stages (T1, T2, T3, or T4a, N0-N3, M0). If you have had chemotherapy or radiation before surgery, that is allowed.
- Your tumor is located in the middle or lower part of the esophagus, or at the esophagogastric junction (types Siewert 1 or 2).
- You are generally healthy enough for surgery, with a performance status of 0, 1, or 2 (you can carry on normal activities or are up and about more than half the day).
- You have not had certain prior surgeries (like an upper abdominal incision called a xyphopubic laparotomy) or trauma to the right chest that might interfere with the procedure.
- You must be willing and able to give written consent, understand the study, and follow the scheduled visits. You also need medical insurance coverage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of surgery for esophageal cancer after you've already had chemotherapy, radiation, or immunotherapy. The goal is to see which surgery is better for removing the cancer and helping you recover.
This study compares two surgical approaches (right side of the chest vs. left side of the chest) for removing a certain type of cancer at the gastroesophageal junction. It aims to find which approach leads to better outcomes.
This trial compares two surgical techniques for treating a specific type of cancer at the junction of the stomach and esophagus. It aims to find which surgery offers better outcomes for patients.
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
This study compares two ways surgeons reconnect the digestive tract after removing the whole stomach for certain stomach cancers near the esophagus. It aims to see which technique is safer and leads to better recovery and outcomes.
This study compares two standard approaches for treating esophageal cancer before surgery: chemotherapy combined with radiation versus chemotherapy combined with immunotherapy. The goal is to see which approach works better for shrinking tumors and improving outcomes in patients whose cancer is considered removable.
Hear when a new Resecable Esophageal or Gastroesophageal Junction Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.